Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for VASC
55.85
-0.15 (-0.27%)
After Hours: 55.85 0.00 (0.00%)
Dec 8, 4:39PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 55.80 - 56.15
52 week 24.34 - 57.15
Open 56.00
Vol / Avg. 484,879.00/191,026.00
Mkt cap 980.98M
P/E 80.86
Div/yield     -
EPS 0.69
Shares 17.53M
Beta 0.95
Inst. own 85%
Jan 19, 2017
Q4 2016 Vascular Solutions Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 13, 2016
Vascular Solutions Inc at Guggenheim Boston Healthcare Conference Add to calendar
Dec 2, 2016
Teleflex Inc Conference Call to Discuss its Definitive Agreement to Acquire Vascular Solutions, Inc. - Webcast
Nov 30, 2016
Vascular Solutions Inc at Piper Jaffray Healthcare Conference
Nov 17, 2016
Vascular Solutions Inc at Canaccord Genuity Med Tech Conference
Nov 16, 2016
Vascular Solutions Inc at Stifel Healthcare Conference
Oct 24, 2016
Q3 2016 Vascular Solutions Inc Earnings Call - Webcast
Oct 24, 2016
Q3 2016 Vascular Solutions Inc Earnings Release
Sep 15, 2016
Vascular Solutions Inc at Credit Suisse Small & Mid Cap Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 13.02% 7.11%
Operating margin 17.32% 9.24%
EBITD margin - 13.31%
Return on average assets 14.30% 7.71%
Return on average equity 15.78% 8.67%
Employees 568 -
CDP Score - -

Address

6464 Sycamore Ct N
MAPLE GROVE, MN 55369-6032
United States - Map
+1-763-6564300 (Phone)
+1-877-6564251 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Howard C. Root Chief Executive Officer and Director
Age: 55
Bio & Compensation  - Reuters
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William Rutstein Senior Vice President - International Sales
Age: 63
Bio & Compensation  - Reuters
Brent Binkowski Senior Vice President - Operations
Age: 47
Bio & Compensation  - Reuters
Chad Kugler Senior Vice President - Research and Development
Age: 44
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 41
Bio & Compensation  - Reuters
Martin J. Emerson Independent Director
Bio & Compensation  - Reuters
Richard W. Kramp Independent Director
Age: 70
Bio & Compensation  - Reuters
Richard J. Nigon Independent Director
Age: 68
Bio & Compensation  - Reuters